Which data and systems are subject to 21 CFR Part 11
View: 231
Website http://www.compliance4all.com/control/w_product/~product_id=501918LIVE?channel=ourglocal_Jun_2018_SE |
Edit Freely
Category Electronic Records and Signatures, 21 cfr part 11 validation, 21 cfr guideline for pharmaceuticals, clinical compliance webinar, Compliance trainings, software product features
Deadline: June 05, 2018 | Date: June 08, 2018
Venue/Country: Online, U.S.A
Updated: 2018-04-18 15:33:32 (GMT+9)
Call For Papers - CFP
Overview:This webinar demystifies Part 11, and get you on the right track for using electronic records and signatures to greatly increase productivity.Areas Covered in the Session:Ensure data integrity, security, and protect intellectual propertyUnderstand the current computer system industry standards for security, data transfer, and audit trailsElectronic signatures, digital pens, and biometric signaturesSOPs required for the IT infrastructureProduct features to look for when purchasing COTS softwareWho Will Benefit:Quality AssuranceQuality ControlLaboratory StaffManagersGMP, GCP, GLP ProfessionalsSpeaker Profile:David Nettleton, is an FDA Compliance Specialist for 21 CFR Part 11, HIPAA, and Computer System Validation. His latest book is "Risk Based Software Validation - Ten easy Steps" that relates to the development, purchase, installation, operation and maintenance of computerized systems used in regulated applications.Event Fee: One Dial-in One Attendee Price: US$150.00Contact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-9407Email: supportcompliance4All.com
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.